TY - JOUR T1 - Hospital at home: a systematic review of how medication management is conceptualised, described and implemented in practice – a study protocol JF - medRxiv DO - 10.1101/2022.05.10.22274917 SP - 2022.05.10.22274917 AU - Sophie McGlen AU - Daniel Lasserson AU - Clare Crowley AU - Zahra AL Qamariat AU - Rosemary H Lim Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/05/10/2022.05.10.22274917.abstract N2 - Introduction Hospital at Home (H@H) is a method of healthcare delivery, where hospital level interventions are conducted in the patient’s usual place of residence, offering an alternative to hospital admission. This often includes the ability to perform point of care diagnostics and treat conditions using a range of treatments traditionally associated with hospital admission, including intravenous medicines and oxygen. H@H services have been established worldwide but there is a wide variation in definition and delivery models and currently no documented evidence supporting the delivery of medicines and medicines management within the H@H model. Therefore, this study aims to 1) describe how medication management in H@H is conceptulised, 2) describe and identify key components of medication management in H@H and 3) describe and identify variability in the implementation of medication management services within H@H modelsMethods and Analysis We will search a range of databases (PubMed, Medline, Embase, CINAHL), publicly accessible documents and expert recommendations. Studies, reports and policy documents published between 1st January 2000 and 31st January 2022 will be included. Two independent reviewers will 1) screen and select studies based on a priori inclusion/exclusion, 2) conduct quality assessment using the Mixed Methods Appraisal Tool on included studies and 3) extract data. Inductive thematic analysis (objectives 1 and 2), the SEIPS 2.0 model (objective 2) and the Consolidated Framework for Implementation Research (objective 3) will be used to synthesise data.Ethics and dissemination This systematic review will use secondary data sources from published documents, and as such research ethical approval was not required. We will disseminate the findings of this study in a peer-reviewed journal and national/international conference(s).PROSPERO registration number CRD42022300691Strengths and limitations of this studyThe search will be performed on a comprehensive range of databases and relevant information sources to capture a global perspective relating to Hospital at Home (H@H).A wide range of search terms will be used in our search, however due to the changing nature of H@H, some terms may be unintentionally missed.Only published literature will be synthesized in this systematic review, and it is recognised that in a rapidly changing environment not all practices will be captured in written form.A combination of thematic synthesis, a work systems model (Systems Engineering Initiative for Patient Safety 2.0) and the Consolidated Framework for Implementation Research will be used to provide a system-level analysis of studies.The study team consists of four pharmacists from a range of practice and research backgrounds and a H@H consultant, therefore, will benefit from different perspectives on the topic area.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableNo datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion. ER -